MedPath

Hangzhou Tangji Medical Technology Co., Ltd.

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:1

Trial Phases

1 Phases

Not Applicable:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
3 (100.0%)

Tangji Gastric Bypass Stent Study for Obesity

Not Applicable
Completed
Conditions
Obesity
First Posted Date
2023-07-10
Last Posted Date
2023-07-10
Lead Sponsor
Hangzhou Tangji Medical Technology Co., Ltd.
Target Recruit Count
99
Registration Number
NCT05938231
Locations
🇨🇳

Beijing Friendship Hospital,Capital Medical University, Beijing, Beijing, China

🇨🇳

Beijing Shijitan Hospital, Capital Medical University, Beijing, Beijing, China

🇨🇳

Nanjing Drum Tower hospital, Nanjing, Jiangsu, China

and more 4 locations

Gastric Bypass Stent Small-Sample-Size Study For Nonalcoholic Fatty Liver Disease

Not Applicable
Recruiting
Conditions
Nonalcoholic Fatty Liver Disease
First Posted Date
2022-08-10
Last Posted Date
2024-06-26
Lead Sponsor
Hangzhou Tangji Medical Technology Co., Ltd.
Target Recruit Count
10
Registration Number
NCT05495139
Locations
🇨🇳

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Tangji EU Gastric Bypass Stent Study for Obesity

Not Applicable
Not yet recruiting
Conditions
Obesity
First Posted Date
2022-02-21
Last Posted Date
2023-03-15
Lead Sponsor
Hangzhou Tangji Medical Technology Co., Ltd.
Target Recruit Count
50
Registration Number
NCT05249608

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.